查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1697434

OTC益生菌补充剂市场：未来预测（2025-2030）

OTC Probiotics Supplement Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计到 2025 年，非处方益生菌补充剂市场价值将达到 169.53 亿美元，复合年增长率为 9.78%，到 2030 年市场规模将达到 270.29 亿美元。

非处方益生菌补充剂市场受到人们日益增强的健康意识的推动，从而导致益生菌补充剂的流行。此外，益生菌应用范围的不断扩大预计将在未来几年推动需求的成长。此外，在美国、德国等已开发国家，人们对免疫力和心理健康的兴趣日益浓厚，对医疗营养的前景看好，推动了市场扩张。此外，非处方益生菌的可用性和便利性正在推动市场成长。

市场趋势：

  • 扩大应用为製造商和供应商创造了成长机会：随着研发力度的加大，益生菌的潜在应用预计在预测期内将扩大。成药益生菌取代其他药物的日子可能即将到来。随着消费者对益生菌健康益处的认识不断提高，预计市场将呈指数级增长。此外，成药益生菌的日益普及以及先进和新型口味益生菌产品的推出预计将进一步扩大製造商和供应商的成长机会。
  • 对创新和便利的益生菌形式的需求不断增长：对软糖、咀嚼片和粉末等便捷的益生菌输送形式的偏好正在推动人们转向更用户友好的选择。
  • 亚太地区的成长：受城市人口成长和可支配收入增加导致的需求增加的推动，亚太地区的非处方益生菌市场预计将快速成长。
  • 北美市场领导地位：受成熟市场和注重健康的消费者的推动，北美占据非处方益生菌补充剂市场的大部分份额。该地区对非处方益生菌产品的购买趋势也日益增长。

报告中介绍的主要企业包括杜邦、达能、Probi AB、Lifeway Foods, Inc.、Kibow Biotech、Pharmavite LLC、Osmotica Pharmaceuticals Corp、Dietary Pros, Inc. 和荷兰皇家帝斯曼。

本报告的主要优点

  • 深刻分析：获得涵盖主要地区和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他子区隔。
  • 竞争格局：了解全球主要企业采取的策略策略，并了解正确策略带来的潜在市场渗透。
  • 市场驱动因素和未来趋势：探索动态因素和关键市场趋势以及它们将如何影响市场的未来发展。
  • 可行的建议：利用洞察力进行策略决策，在动态环境中开闢新的业务流和收益。
  • 适用范围广：对于新兴企业、研究机构、顾问公司、中小企业和大型企业来说，它都是实用且具有成本效益的。

它有什么用途？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024）和预测资料（2025-2030）
  • 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按部门和地区（国家）分類的收益成长和预测分析
  • 公司概况（策略、产品、财务资讯、主要趋势等）

OTC益生菌补充剂市场细分为：

按形状

  • 胶囊
  • 锭剂
  • 粉末/糖浆

按成分

  • Bacteria
  • Lactobacilli
  • Bifidobacterium
  • Streptococcus Thermophilus
  • Yeast

按健康类别

  • 肠道健康
  • 整体健康
  • 免疫力
  • 心理健康
  • 其他的

按分销管道

  • 在线的
  • 离线

按地区

  • 北美洲
  • 欧洲
  • 亚太地区
  • 南美洲
  • 中东和非洲

目录

第一章 引言

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益

第二章分析方法

  • 分析设计
  • 分析过程

第三章执行摘要

  • 主要发现

第四章 市场动态

  • 市场驱动因素
  • 市场限制
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

5. 非处方益生菌补充剂市场（按形式）

  • 介绍
  • 胶囊
  • 锭剂
  • 粉末/糖浆

6. 非处方益生菌补充剂市场（依成分）

  • 介绍
  • 细菌
    • 乳酸菌
    • 双歧桿菌
    • 嗜热链球菌
  • 酵母菌

7. 非处方益生菌补充剂市场（依健康类别）

  • 介绍
  • 肠道健康
  • 一般健康
  • 免疫
  • 心理健康
  • 其他的

8. 非处方益生菌补充剂市场（依分销管道）

  • 介绍
  • 在线的
  • 离线

9. 非处方益生菌补充剂市场（按地区）

  • 介绍
  • 北美洲
    • 按形状
    • 按成分
    • 按健康类别
    • 按分销管道
    • 按国家
  • 南美洲
    • 按形状
    • 按成分
    • 按健康类别
    • 按分销管道
    • 按国家
  • 欧洲
    • 按形状
    • 按成分
    • 按健康类别
    • 按分销管道
    • 按国家
  • 中东和非洲
    • 按形状
    • 按成分
    • 按健康类别
    • 按分销管道
    • 按国家
  • 亚太地区
    • 按形状
    • 按成分
    • 按健康类别
    • 按分销管道
    • 按国家

第十章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 企业合併、协议、商业合作
  • 竞争仪錶板

第十一章 公司简介

  • DuPont
  • Danone
  • Probi AB
  • Lifeway Foods, Inc.
  • Kibow Biotech
  • Pharmavite LLC
  • Osmotica Pharmaceuticals Corp
  • Dietary Pros, Inc.
  • Royal DSM

第十二章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 分析方法
  • 简称
简介目录
Product Code: KSI061613807

The OTC Probiotics Supplement Market, valued at US$16.953 billion in 2025, is projected to grow at a CAGR of 9.78%, reaching a market size of US$27.029 billion by 2030.

The market for OTC probiotics supplements is driven by rising health awareness among individuals, leading to the popularity of probiotic supplements. In addition, the expanding scope of probiotics application is anticipated to boost the demand in the coming years. Furthermore, there is a favorable outlook of people toward medical nutrition in developed countries like the United States and Germany, among others, due to an increased focus on immunity and mental health, which is driving market expansion. Moreover, OTC probiotics' easy availability and convenience are propelling the market growth.

Market Trends:

  • Expanding Applications Create Growth Opportunities for Manufacturers and Vendors: With increasing research and development efforts, the potential applications of probiotics are expected to broaden during the forecast period. OTC pharmaceutical probiotics may soon replace other pharmaceutical agents. The market is poised for exponential growth as consumer awareness of the health benefits of probiotics rises. Additionally, the introduction of advanced and new flavored probiotic products, along with the growing popularity of OTC pharmaceutical probiotics, is expected to further expand growth opportunities for manufacturers and vendors.
  • Rising Demand for Innovative and Convenient Probiotic Formats: There is a growing preference for convenient probiotic delivery formats such as gummies, chewables, and powders, driving a shift toward more user-friendly options.
  • Asia-Pacific Growth: The Asia-Pacific region is expected to experience rapid growth in the OTC probiotics market, fueled by increasing demand from the expanding urban population and rising disposable incomes.
  • North America's Market Leadership: North America holds a significant share of the OTC probiotics supplement market, supported by its established market and health-conscious consumers. The region is also witnessing a growing trend toward targeted OTC probiotic products.

Some of the major players covered in this report include DuPont, Danone, Probi AB, Lifeway Foods, Inc., Kibow Biotech, Pharmavite LLC, Osmotica Pharmaceuticals Corp, Dietary Pros, Inc., and Royal DSM, among others.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

OTC Probiotics Supplement Market is analyzed into the following segments:

By Form

  • Capsules
  • Tablets
  • Powder & Syrups

By Ingredients

  • Bacteria
  • Lactobacilli
  • Bifidobacterium
  • Streptococcus Thermophilus
  • Yeast

By Health Area

  • Gut Health
  • General Health
  • Immunity
  • Mental Well-Being
  • Others

By Distribution Channel

  • Online
  • Offline

By Region

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. OTC PROBIOTICS SUPPLEMENT MARKET BY FORM

  • 5.1. Introduction
  • 5.2. Capsules
  • 5.3. Tablets
  • 5.4. Powder & Syrups

6. OTC PROBIOTICS SUPPLEMENT MARKET BY INGREDIENTS

  • 6.1. Introduction
  • 6.2. Bacteria
    • 6.2.1. Lactobacilli
    • 6.2.2. Bifidobacterium
    • 6.2.3. Streptococcus Thermophilus
  • 6.3. Yeast

7. OTC PROBIOTICS SUPPLEMENT MARKET BY HEALTH AREA

  • 7.1. Introduction
  • 7.2. Gut Health
  • 7.3. General Health
  • 7.4. Immunity
  • 7.5. Mental Well-Being
  • 7.6. Others

8. OTC PROBIOTICS SUPPLEMENT MARKET BY DISTRIBUTION CHANNEL

  • 8.1. Introduction
  • 8.2. Online
  • 8.3. Offline

9. OTC PROBIOTICS SUPPLEMENT MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Form
    • 9.2.2. By Ingredients
    • 9.2.3. By Health Area
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country
      • 9.2.5.1. USA
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. South America
    • 9.3.1. By Form
    • 9.3.2. By Ingredients
    • 9.3.3. By Health Area
    • 9.3.4. By Distribution Channel
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
      • 9.3.5.2. Argentina
      • 9.3.5.3. Others
  • 9.4. Europe
    • 9.4.1. By Form
    • 9.4.2. By Ingredients
    • 9.4.3. By Health Area
    • 9.4.4. By Distribution Channel
    • 9.4.5. By Country
      • 9.4.5.1. United Kingdom
      • 9.4.5.2. Germany
      • 9.4.5.3. France
      • 9.4.5.4. Spain
      • 9.4.5.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. By Form
    • 9.5.2. By Ingredients
    • 9.5.3. By Health Area
    • 9.5.4. By Distribution Channel
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
      • 9.5.5.2. UAE
      • 9.5.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. By Form
    • 9.6.2. By Ingredients
    • 9.6.3. By Health Area
    • 9.6.4. By Distribution Channel
    • 9.6.5. By Country
      • 9.6.5.1. China
      • 9.6.5.2. Japan
      • 9.6.5.3. India
      • 9.6.5.4. South Korea
      • 9.6.5.5. Taiwan
      • 9.6.5.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. DuPont
  • 11.2. Danone
  • 11.3. Probi AB
  • 11.4. Lifeway Foods, Inc.
  • 11.5. Kibow Biotech
  • 11.6. Pharmavite LLC
  • 11.7. Osmotica Pharmaceuticals Corp
  • 11.8. Dietary Pros, Inc.
  • 11.9. Royal DSM

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key benefits for the stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations